speb/financial-data huggingface dataset:
Financial ratios for CRTO — quarterly report dated 2025-09-30
Total revenue: 552541176.4705882
Gross profit: 301744705.88235295
Operating income: 60740000
Net income: 47149411.76470588
Capital expenditures: 27021176.470588237
Operating cash flow: 105411764.70588236
Depreciation & amortization: 43098823.52941176
Net tangible assets: 515984705.88235295
Owner earnings: 63227058.82352941
Return on net tangible assets (%): 12.253669169400824
Capex to operating income (%): 44.48662573359934
Buffett classification: The Good
Stock price: 22.6
P/E ratio: 9.655480045268614
Shares outstanding: 50244527
Book value: 1377572941.1764708
P/B ratio: 0.8242948712612207
Market cap (USD): 1135526310.2
Debt to equity: 0.09335088053413633
Current ratio: 1.3318094895034882
Quick ratio: 1.3318094895034882
Effective tax rate (%): 22.343435126337
Interest coverage ratio: 72.20839160839161
COGS to revenue (%): 45.38964357194566
R&D to revenue (%): 14.409998722480093
SG&A to revenue (%): 29.20751181705915
Free cash flow (dilution-adjusted): 60928235.294117644
Buyback yield (%): 1.1342757877385903
Retained earnings: 778230588.2352941
Receivables turnover: 0.701402775682832
Capitalized R&D asset: 164162990.40920714
ROCI (R&D-adjusted, %): 3.559928109676442
Rosenberg metric: -0.02556211531214694
FCF margin (%): 11.026913086062258
Revenue growth (%): -2.6956249702178208
Rule of 40 score: 8.331288115844437
Financial ratios for CRTO — annual report dated 2025-12-31
Total revenue: 2288118823.529412
Gross profit: 1234564705.882353
Operating income: 238547058.82352942
Net income: 175740000
Capital expenditures: 120869411.76470588
Operating cash flow: 366161176.47058827
Depreciation & amortization: 152289411.7647059
Net tangible assets: 543054117.6470588
Owner earnings: 207160000
Return on net tangible assets (%): 38.14721098103103
Capex to operating income (%): 50.66900106034079
Buffett classification: The Good
Stock price: 20.61
P/E ratio: 5.8924530640150214
Shares outstanding: 50244527
Book value: 1394975294.1176472
P/B ratio: 0.7423355136371801
Market cap (USD): 1035539701.47
Debt to equity: 0.11668939530027518
Current ratio: 1.2690107428603903
Quick ratio: 1.2690107428603903
Effective tax rate (%): 26.6217689881812
Interest coverage ratio: 82.3913043478261
COGS to revenue (%): 46.04455445290017
R&D to revenue (%): 14.566448369351448
SG&A to revenue (%): 28.963530791541576
Free cash flow (dilution-adjusted): 177235294.11764708
Buyback yield (%): 17.27590195484113
Retained earnings: 742058823.5294118
Receivables turnover: 2.976653887065053
Capitalized R&D asset: 617093686.6421568
ROCI (R&D-adjusted, %): 12.381864755588474
Rosenberg metric: 0.7238862810939279
FCF margin (%): 7.745895549439279
Revenue growth (%): 13.6195400991903
Rule of 40 score: 21.36543564862958
Financial ratios for CRTO — quarterly report dated 2025-12-31
Total revenue: 636630588.2352941
Gross profit: 349885882.3529412
Operating income: 85310588.23529412
Net income: 56049411.76470588
Capital expenditures: 32269411.76470588
Operating cash flow: 189050588.23529413
Depreciation & amortization: 38031764.705882356
Net tangible assets: 543054117.6470588
Owner earnings: 61811764.705882356
Return on net tangible assets (%): 11.382247679789254
Capex to operating income (%): 37.82579915602504
Buffett classification: The Good
Stock price: 20.61
P/E ratio: 5.9632442174964835
Shares outstanding: 50244527
Book value: 1394975294.1176472
P/B ratio: 0.7423355136371801
Market cap (USD): 1035539701.47
Debt to equity: 0.11668939530027518
Current ratio: 1.2690107428603903
Quick ratio: 1.2690107428603903
Effective tax rate (%): 36.341172109880155
Interest coverage ratio: 110.03641881638848
COGS to revenue (%): 45.04098784778688
R&D to revenue (%): 13.908887969013334
SG&A to revenue (%): 27.649795984743207
Free cash flow (dilution-adjusted): 149944705.88235295
Buyback yield (%): 4.160376746542787
Retained earnings: 742058823.5294118
Receivables turnover: 0.8282038920391499
Capitalized R&D asset: 172801835.29411763
ROCI (R&D-adjusted, %): 4.895147104595847
Rosenberg metric: 0.6046277963296791
FCF margin (%): 23.55285917033796
Revenue growth (%): 15.218668824255849
Rule of 40 score: 38.77152799459381
Financial ratios for DRS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.29
Shares outstanding: 266762087
Market cap (USD): 2478219788.2299995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRS — annual report dated 2022-12-31
Total revenue: 2693000000
Gross profit: 575000000
Operating income: 561000000
Net income: 405000000
Capital expenditures: 65000000
Operating cash flow: 33000000
Depreciation & amortization: 65000000
Net tangible assets: 719000000
Owner earnings: 405000000
Return on net tangible assets (%): 56.32823365785814
Capex to operating income (%): 11.58645276292335
Buffett classification: The Great
Stock price: 12.6
P/E ratio: 8.299264928888888
Shares outstanding: 266762087
Book value: 2127000000
P/B ratio: 1.5802549582510577
Market cap (USD): 3361202296.2
Debt to equity: 0.22896097790314998
Current ratio: 1.6381957773512477
Quick ratio: 1.3320537428023032
Effective tax rate (%): 22.857142857142858
Interest coverage ratio: 16.5
COGS to revenue (%): 78.64834756776828
SG&A to revenue (%): 13.256591162272557
Free cash flow (dilution-adjusted): -37000000
Buyback yield (%): 0
Retained earnings: -2974000000
Inventory turnover: 6.639498432601881
Receivables turnover: 2.5944123314065513
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.29032258064516
FCF margin (%): -1.3739324173783884
Rule of 40 score: -1.3739324173783884
Financial ratios for DRS — annual report dated 2023-12-31
Total revenue: 2826000000
Gross profit: 648000000
Operating income: 231000000
Net income: 168000000
Capital expenditures: 60000000
Operating cash flow: 205000000
Depreciation & amortization: 85000000
Net tangible assets: 936000000
Owner earnings: 193000000
Return on net tangible assets (%): 20.61965811965812
Capex to operating income (%): 25.97402597402597
Buffett classification: The Good
Stock price: 19.76
P/E ratio: 31.37630261380953
Shares outstanding: 266762087
Book value: 2325000000
P/B ratio: 2.267190898546237
Market cap (USD): 5271218839.120001
Debt to equity: 0.21376344086021506
Current ratio: 1.7792207792207793
Quick ratio: 1.474025974025974
Effective tax rate (%): 12.5
Interest coverage ratio: 6.416666666666667
COGS to revenue (%): 77.07006369426752
SG&A to revenue (%): 13.588110403397028
Free cash flow (dilution-adjusted): 128000000
Buyback yield (%): 0
Retained earnings: -2806000000
Inventory turnover: 6.620060790273556
Receivables turnover: 2.668555240793201
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.125219838199085
FCF margin (%): 4.529370134465676
Revenue growth (%): 4.9387300408466395
Rule of 40 score: 9.468100175312316
Financial ratios for DRS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.83
Shares outstanding: 266762087
Market cap (USD): 7423988881.209999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.86
Shares outstanding: 266762087
Market cap (USD): 8499040091.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRS — annual report dated 2024-12-31
Total revenue: 3234000000
Gross profit: 736000000
Operating income: 293000000
Net income: 213000000
Capital expenditures: 85000000
Operating cash flow: 271000000
Depreciation & amortization: 91000000
Net tangible assets: 1187000000
Owner earnings: 219000000
Return on net tangible assets (%): 18.44987363100253
Capex to operating income (%): 29.01023890784983
Buffett classification: The Good
Stock price: 31.86
P/E ratio: 39.901596675211266
Shares outstanding: 266762087
Book value: 2557000000
P/B ratio: 3.323832652256551
Market cap (USD): 8499040091.82
Debt to equity: 0.1791161517403207
Current ratio: 1.9381720430107527
Quick ratio: 1.6173835125448028
Effective tax rate (%): 19.318181818181817
Interest coverage ratio: 13.952380952380953
COGS to revenue (%): 77.2418058132344
SG&A to revenue (%): 12.80148423005566
Free cash flow (dilution-adjusted): 164000000
Buyback yield (%): 0
Retained earnings: -2593000000
Inventory turnover: 6.977653631284916
Receivables turnover: 2.8746666666666667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.550195567144721
FCF margin (%): 5.071119356833643
Revenue growth (%): 14.437367303609342
Rule of 40 score: 19.508486660442983
Financial ratios for DRS — quarterly report dated 2025-03-31
Total revenue: 799000000
Gross profit: 181000000
Operating income: 59000000
Net income: 50000000
Capital expenditures: 32000000
Operating cash flow: -138000000
Depreciation & amortization: 23000000
Net tangible assets: 1207000000
Owner earnings: 41000000
Return on net tangible assets (%): 3.396851698425849
Capex to operating income (%): 54.23728813559322
Buffett classification: The Good
Stock price: 32.52
P/E ratio: 43.375515346200004
Shares outstanding: 266762087
Book value: 2571000000
P/B ratio: 3.37421356252042
Market cap (USD): 8675103069.240002
Debt to equity: 0.17580707895760406
Current ratio: 2.015579357351509
Quick ratio: 1.6407010710808179
Effective tax rate (%): 13.793103448275861
Interest coverage ratio: 59
COGS to revenue (%): 77.34668335419273
SG&A to revenue (%): 14.643304130162704
Free cash flow (dilution-adjusted): -178000000
Buyback yield (%): 0.034581721693167394
Retained earnings: -2543000000
Inventory turnover: 1.6051948051948053
Receivables turnover: 0.6464401294498382
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9224503095470837
FCF margin (%): -22.27784730913642
Rule of 40 score: -22.27784730913642
Financial ratios for DRS — quarterly report dated 2025-06-30
Total revenue: 829000000
Gross profit: 197000000
Operating income: 70000000
Net income: 54000000
Capital expenditures: 28000000
Operating cash flow: -28000000
Depreciation & amortization: 23000000
Net tangible assets: 1242000000
Owner earnings: 49000000
Return on net tangible assets (%): 3.9452495974235107
Capex to operating income (%): 40
Buffett classification: The Good
Stock price: 46.07
P/E ratio: 118.17047450086538
Shares outstanding: 266762087
Book value: 2600000000
P/B ratio: 4.726818980034615
Market cap (USD): 12289729348.09
Debt to equity: 0.18153846153846154
Current ratio: 2.113778705636743
Quick ratio: 1.696242171189979
Effective tax rate (%): 19.402985074626866
Interest coverage ratio: 35
COGS to revenue (%): 76.23642943305187
SG&A to revenue (%): 14.595898673100121
Free cash flow (dilution-adjusted): -62000000
Buyback yield (%): 0.08950563261760974
Retained earnings: -2489000000
Inventory turnover: 1.58
Receivables turnover: 0.6471506635441062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.242870874719641
FCF margin (%): -7.478890229191798
Revenue growth (%): 3.754693366708386
Rule of 40 score: -3.724196862483412
Financial ratios for DRS — quarterly report dated 2025-09-30
Total revenue: 960000000
Gross profit: 222000000
Operating income: 93000000
Net income: 72000000
Capital expenditures: 30000000
Operating cash flow: 107000000
Depreciation & amortization: 23000000
Net tangible assets: 1296000000
Owner earnings: 65000000
Return on net tangible assets (%): 5.015432098765432
Capex to operating income (%): 32.25806451612903
Buffett classification: The Good
Stock price: 45.1
P/E ratio: 68.35778479375
Shares outstanding: 266762087
Book value: 2648000000
P/B ratio: 4.543417720430514
Market cap (USD): 12030970123.7
Debt to equity: 0.1778700906344411
Current ratio: 2.0018484288354896
Quick ratio: 1.6284658040665434
Effective tax rate (%): 17.24137931034483
Interest coverage ratio: 23.25
COGS to revenue (%): 76.875
SG&A to revenue (%): 12.812499999999998
Free cash flow (dilution-adjusted): 72000000
Buyback yield (%): 0.08311881666384359
Retained earnings: -2417000000
Inventory turnover: 1.8267326732673268
Receivables turnover: 0.6951484431571325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9402466013278534
FCF margin (%): 7.5
Revenue growth (%): 15.8021712907117
Rule of 40 score: 23.302171290711698
Financial ratios for DRS — quarterly report dated 2025-12-31
Total revenue: 1060000000
Gross profit: 269000000
Operating income: 126000000
Net income: 102000000
Capital expenditures: 49000000
Operating cash flow: 425000000
Depreciation & amortization: 24000000
Net tangible assets: 1380000000
Owner earnings: 77000000
Return on net tangible assets (%): 5.579710144927536
Capex to operating income (%): 38.88888888888889
Buffett classification: The Good
Stock price: 33.95
P/E ratio: 32.577600192985614
Shares outstanding: 266762087
Book value: 2730000000
P/B ratio: 3.317425953717949
Market cap (USD): 9056572853.650002
Debt to equity: 0.17216117216117216
Current ratio: 1.8895207148659627
Quick ratio: 1.60357432981316
Effective tax rate (%): 17.741935483870968
Interest coverage ratio: 126
COGS to revenue (%): 74.62264150943396
SG&A to revenue (%): 12.830188679245284
Free cash flow (dilution-adjusted): 363000000
Buyback yield (%): 0.12145874800274757
Retained earnings: -2315000000
Inventory turnover: 2.247159090909091
Receivables turnover: 0.8379446640316206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.870967741935484
FCF margin (%): 34.24528301886792
Revenue growth (%): 10.416666666666668
Rule of 40 score: 44.661949685534594
Financial ratios for DRS — annual report dated 2025-12-31
Total revenue: 3648000000
Gross profit: 869000000
Operating income: 348000000
Net income: 278000000
Capital expenditures: 139000000
Operating cash flow: 366000000
Depreciation & amortization: 93000000
Net tangible assets: 1380000000
Owner earnings: 232000000
Return on net tangible assets (%): 16.81159420289855
Capex to operating income (%): 39.94252873563218
Buffett classification: The Good
Stock price: 33.95
P/E ratio: 32.577600192985614
Shares outstanding: 266762087
Book value: 2730000000
P/B ratio: 3.317425953717949
Market cap (USD): 9056572853.650002
Debt to equity: 0.17216117216117216
Current ratio: 1.8895207148659627
Quick ratio: 1.60357432981316
Effective tax rate (%): 17.261904761904763
Interest coverage ratio: 43.5
COGS to revenue (%): 76.17872807017544
SG&A to revenue (%): 13.623903508771928
Free cash flow (dilution-adjusted): 195000000
Buyback yield (%): 0.386459652736015
Retained earnings: -2315000000
Inventory turnover: 7.894886363636363
Receivables turnover: 2.883794466403162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.691244239631336
FCF margin (%): 5.345394736842105
Revenue growth (%): 12.80148423005566
Rule of 40 score: 18.146878966897766
Financial ratios for DSGX — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 72.77
Shares outstanding: 85690827
Market cap (USD): 6235721480.79
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSGX — annual report dated 2023-01-31
Total revenue: 362697014.92537314
Gross profit: 278125373.13432837
Operating income: 101399253.73134328
Net income: 76295522.38805969
Capital expenditures: 4530597.014925373
Operating cash flow: 143578358.20895523
Depreciation & amortization: 48807462.686567165
Net tangible assets: 144728358.20895523
Owner earnings: 120572388.05970149
Return on net tangible assets (%): 83.30944229024007
Capex to operating income (%): 4.468077276908923
Buffett classification: The Great
Stock price: 73.02
P/E ratio: 82.01194502233656
Shares outstanding: 85690827
Book value: 820441044.7761194
P/B ratio: 7.626561624848303
Market cap (USD): 6257144187.54
Debt to equity: 0.006658231693728619
Current ratio: 2.1147498452194933
Quick ratio: 2.110274477431528
Effective tax rate (%): 23.549294089495096
Interest coverage ratio: 116.43101970865467
COGS to revenue (%): 23.31743530021769
R&D to revenue (%): 14.475508935956578
SG&A to revenue (%): 21.868300090120858
Free cash flow (dilution-adjusted): 128848507.46268655
Buyback yield (%): 0
Retained earnings: 78244776.11940297
Inventory turnover: 149.30961791831356
Receivables turnover: 8.551917087505059
Capitalized R&D asset: 52502238.80597015
ROCI (R&D-adjusted, %): 15.021096283536684
FCF margin (%): 35.52510833021271
Rule of 40 score: 35.52510833021271
Financial ratios for DSGX — annual report dated 2024-01-31
Total revenue: 427560447.761194
Gross profit: 324355223.880597
Operating income: 122759701.4925373
Net income: 86497761.19402985
Capital expenditures: 4151492.5373134324
Operating cash flow: 154985074.62686566
Depreciation & amortization: 49235074.62686567
Net tangible assets: 169085074.62686566
Owner earnings: 131581343.28358209
Return on net tangible assets (%): 77.81960860469428
Capex to operating income (%): 3.3818040340915996
Buffett classification: The Great
Stock price: 87.59
P/E ratio: 86.77287635333673
Shares outstanding: 85690827
Book value: 923905970.1492537
P/B ratio: 8.12383487003281
Market cap (USD): 7505659536.93
Debt to equity: 0.005636355705901454
Current ratio: 2.05363649756912
Quick ratio: 2.05363649756912
Effective tax rate (%): 23.317587593945166
Interest coverage ratio: 120.68818782098313
COGS to revenue (%): 24.13815974349442
R&D to revenue (%): 14.679429111009878
SG&A to revenue (%): 21.91084092150713
Free cash flow (dilution-adjusted): 138535074.62686566
Buyback yield (%): 0
Retained earnings: 164742537.3134328
Receivables turnover: 8.985461560176907
Capitalized R&D asset: 97939932.83582088
ROCI (R&D-adjusted, %): 14.060663285332836
Rosenberg metric: 0.8805310363452868
FCF margin (%): 32.401283924242186
Revenue growth (%): 17.883641211981534
Rule of 40 score: 50.28492513622372
Financial ratios for DSGX — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 103.93
Shares outstanding: 85690827
Market cap (USD): 8905847650.11
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSGX — quarterly report dated 2025-01-31
Total revenue: 115497241.37931035
Gross profit: 88284137.93103449
Operating income: 33568275.862068966
Net income: 25770344.827586208
Capital expenditures: 1441379.3103448276
Operating cash flow: 41879310.344827585
Depreciation & amortization: 14406206.896551725
Net tangible assets: 95846896.55172414
Owner earnings: 38735172.4137931
Return on net tangible assets (%): 40.41359064024522
Capex to operating income (%): 4.293873525907054
Buffett classification: The Great
Stock price: 115.83
P/E ratio: 96.2886658853032
Shares outstanding: 85690827
Book value: 955174482.7586207
P/B ratio: 10.39136688696306
Market cap (USD): 9925568491.41
Debt to equity: 0.005701070683601407
Current ratio: 1.6245259806383539
Quick ratio: 1.621231459680132
Effective tax rate (%): 23.29939652695103
Interest coverage ratio: 199.48360655737702
COGS to revenue (%): 23.561691277892887
R&D to revenue (%): 14.88317380322563
SG&A to revenue (%): 20.884809907386952
Free cash flow (dilution-adjusted): 36722758.62068966
Buyback yield (%): 0
Retained earnings: 251053793.10344827
Inventory turnover: 55.18741258741259
Receivables turnover: 2.362606512047853
Capitalized R&D asset: 17189655.172413792
ROCI (R&D-adjusted, %): 4.4864615013905675
FCF margin (%): 31.795355613807764
Rule of 40 score: 31.795355613807764
Financial ratios for DSGX — annual report dated 2025-01-31
Total revenue: 448965517.2413793
Gross profit: 339604137.9310345
Operating income: 130062068.96551725
Net income: 98808965.51724139
Capital expenditures: 4650344.827586207
Operating cash flow: 151222068.96551725
Depreciation & amortization: 51715862.06896552
Net tangible assets: 95846896.55172414
Owner earnings: 145874482.7586207
Return on net tangible assets (%): 152.19531148814923
Capex to operating income (%): 3.5754812026088336
Buffett classification: The Great
Stock price: 115.83
P/E ratio: 100.4521041127393
Shares outstanding: 85690827
Book value: 955174482.7586207
P/B ratio: 10.39136688696306
Market cap (USD): 9925568491.41
Debt to equity: 0.005701070683601407
Current ratio: 1.6245259806383539
Quick ratio: 1.621231459680132
Effective tax rate (%): 25.235737059900952
Interest coverage ratio: 187.83864541832668
COGS to revenue (%): 24.35852534562212
R&D to revenue (%): 14.66927803379416
SG&A to revenue (%): 21.342549923195087
Free cash flow (dilution-adjusted): 132804827.58620691
Buyback yield (%): 0
Retained earnings: 251053793.10344827
Inventory turnover: 221.78181818181818
Receivables turnover: 9.184018960555273
Capitalized R&D asset: 125237238.80597015
ROCI (R&D-adjusted, %): 12.192859821923358
Rosenberg metric: 0.24295857255491796
FCF margin (%): 29.580184331797238
Revenue growth (%): 5.006325910702745
Rule of 40 score: 34.58651024249998
Financial ratios for DSGX — quarterly report dated 2025-04-30
Total revenue: 122274637.68115944
Gross profit: 93472463.76811595
Operating income: 35976086.95652174
Net income: 26263768.11594203
Capital expenditures: 1349275.3623188406
Operating cash flow: 38842753.623188406
Depreciation & amortization: 14901449.27536232
Net tangible assets: 66346376.81159421
Owner earnings: 39815942.02898551
Return on net tangible assets (%): 60.01223268310797
Capex to operating income (%): 3.7504783773440487
Buffett classification: The Great
Stock price: 105.39
P/E ratio: 85.9640191162082
Shares outstanding: 85690827
Book value: 1052128260.8695652
P/B ratio: 8.58351266989642
Market cap (USD): 9030956257.53
Debt to equity: 0.005465113155736096
Current ratio: 1.3507562257253825
Quick ratio: 1.3507562257253825
Effective tax rate (%): 24.371922210166094
Interest coverage ratio: 210.36864406779662
COGS to revenue (%): 23.55531323523311
R&D to revenue (%): 14.856672138628294
SG&A to revenue (%): 20.83809907608792
Free cash flow (dilution-adjusted): 34329710.14492754
Buyback yield (%): 0
Retained earnings: 290052173.9130435
Receivables turnover: 2.217274184646921
Capitalized R&D asset: 29683010.99450275
ROCI (R&D-adjusted, %): 3.8154260963865037
Rosenberg metric: 0.3018283837018303
FCF margin (%): 28.075904207089053
Revenue growth (%): 5.868015738653956
Rule of 40 score: 33.94391994574301
Financial ratios for DSGX — quarterly report dated 2025-07-31
Total revenue: 130300724.63768117
Gross profit: 100164492.7536232
Operating income: 38624637.68115942
Net income: 27550724.63768116
Capital expenditures: 898550.7246376813
Operating cash flow: 45895652.17391305
Depreciation & amortization: 15945652.173913045
Net tangible assets: 114031884.05797103
Owner earnings: 42597826.08695652
Return on net tangible assets (%): 37.35606619048829
Capex to operating income (%): 2.3263667404600206
Buffett classification: The Great
Stock price: 105.76
P/E ratio: 113.87422703818856
Shares outstanding: 85690827
Book value: 1086873913.0434785
P/B ratio: 8.338282623917816
Market cap (USD): 9062661863.52
Debt to equity: 0.005316404046707549
Current ratio: 1.702222348071904
Quick ratio: 1.702222348071904
Effective tax rate (%): 23.176399272580323
Interest coverage ratio: 219.34979423868313
COGS to revenue (%): 23.12821510997414
R&D to revenue (%): 14.877512999471678
SG&A to revenue (%): 20.948752884909492
Free cash flow (dilution-adjusted): 41770289.85507247
Buyback yield (%): 0
Retained earnings: 317602898.5507247
Receivables turnover: 2.2352816866391527
Capitalized R&D asset: 37229274.61269365
ROCI (R&D-adjusted, %): 3.4392251637066162
Rosenberg metric: 0.36838326219633827
FCF margin (%): 32.056836192753664
Revenue growth (%): 6.56398343003099
Rule of 40 score: 38.62081962278465
Financial ratios for DSGX — quarterly report dated 2025-10-31
Total revenue: 134057857.14285715
Gross profit: 103720714.2857143
Operating income: 40937857.14285714
Net income: 31356428.571428575
Capital expenditures: 854285.7142857143
Operating cash flow: 52400000
Depreciation & amortization: 15837142.857142858
Net tangible assets: 131702142.85714287
Owner earnings: 46339285.71428572
Return on net tangible assets (%): 35.18491401051073
Capex to operating income (%): 2.086786592919582
Buffett classification: The Great
Stock price: 88.21
P/E ratio: 68.13323943202775
Shares outstanding: 85690827
Book value: 1108344285.7142859
P/B ratio: 6.819891568979982
Market cap (USD): 7558787849.669999
Debt to equity: 0.0048998441691016584
Current ratio: 1.8343089460638602
Quick ratio: 1.8333622968362713
Effective tax rate (%): 24.75188124582183
Interest coverage ratio: 234.88934426229508
COGS to revenue (%): 22.62988794816737
R&D to revenue (%): 14.170320916874909
SG&A to revenue (%): 21.63671335937042
Free cash flow (dilution-adjusted): 47302142.857142866
Buyback yield (%): 0
Retained earnings: 344422142.85714287
Inventory turnover: 205.17874396135264
Receivables turnover: 2.1437986886893747
Capitalized R&D asset: 37979479.296066254
ROCI (R&D-adjusted, %): 3.474793162230841
Rosenberg metric: 0.18344743250170875
FCF margin (%): 35.28487167054737
Revenue growth (%): 2.8834317810765784
Rule of 40 score: 38.16830345162395
Financial ratios for DSGX — annual report dated 2026-01-31
Total revenue: 539994074.074074
Gross profit: 416242222.2222222
Operating income: 163264444.44444445
Net income: 121308888.88888888
Capital expenditures: 4244444.444444444
Operating cash flow: 197219259.25925925
Depreciation & amortization: 64541481.48148148
Net tangible assets: 193377777.77777776
Owner earnings: 181605925.9259259
Return on net tangible assets (%): 93.91251053397687
Capex to operating income (%): 2.5997359430508102
Buffett classification: The Great
Stock price: 74.76
P/E ratio: 52.8093718869003
Shares outstanding: 85690827
Book value: 1199194074.0740738
P/B ratio: 5.342126320517732
Market cap (USD): 6406246226.52
Debt to equity: 0.005165815065920816
Current ratio: 2.1595661756800344
Quick ratio: 2.159113715371107
Effective tax rate (%): 24.562623796582063
Interest coverage ratio: 227.92864529472595
COGS to revenue (%): 22.91726109477196
R&D to revenue (%): 14.445974715771914
SG&A to revenue (%): 21.26593981826961
Free cash flow (dilution-adjusted): 177488148.14814815
Buyback yield (%): 0.010314007881955361
Retained earnings: 390351851.8518518
Inventory turnover: 1654.1089108910894
Receivables turnover: 7.99123037797071
Capitalized R&D asset: 142845540.2432283
ROCI (R&D-adjusted, %): 12.477097944668882
Rosenberg metric: 1.163651446875003
FCF margin (%): 32.86853628023353
Revenue growth (%): 20.27517778915627
Rule of 40 score: 53.1437140693898
Financial ratios for DSGX — quarterly report dated 2026-01-31
Total revenue: 142782962.96296296
Gross profit: 110740000
Operating income: 44551851.85185185
Net income: 33780740.74074074
Capital expenditures: 1060740.7407407407
Operating cash flow: 56257037.03703703
Depreciation & amortization: 16585185.185185185
Net tangible assets: 193377777.77777776
Owner earnings: 49305185.18518519
Return on net tangible assets (%): 25.496820654255732
Capex to operating income (%): 2.3809127940809707
Buffett classification: The Great
Stock price: 74.76
P/E ratio: 53.855878222001536
Shares outstanding: 85690827
Book value: 1199194074.0740738
P/B ratio: 5.342126320517732
Market cap (USD): 6406246226.52
Debt to equity: 0.005165815065920816
Current ratio: 2.1595661756800344
Quick ratio: 2.159113715371107
Effective tax rate (%): 25.65009700507035
Interest coverage ratio: 246.49590163934428
COGS to revenue (%): 22.441727148689804
R&D to revenue (%): 13.952281888595486
SG&A to revenue (%): 21.575351349107947
Free cash flow (dilution-adjusted): 50642962.962962955
Buyback yield (%): 0
Retained earnings: 390351851.8518518
Inventory turnover: 428.29702970297035
Receivables turnover: 2.1130075418749454
Capitalized R&D asset: 39046306.01564298
ROCI (R&D-adjusted, %): 3.5244667650079533
Rosenberg metric: 0.3695055461552917
FCF margin (%): 35.468491416654125
Revenue growth (%): 6.5084628428813405
Rule of 40 score: 41.97695425953547
Financial ratios for DSV.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 118414.07874015748
Buffett classification: The Gruesome
Stock price: 1.6377952755905512
Shares outstanding: 810857272
Market cap (USD): 1328018209.2598424
Buyback yield (%): 0
Capitalized R&D asset: 1703.9370078740158
Rule of 40 score: 0
Financial ratios for DSV.TO — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -35898.95588235294
Operating income: -24961452.860294115
Net income: -22264572.602941174
Capital expenditures: 221353.75735294115
Operating cash flow: -21186512.345588233
Depreciation & amortization: 156755.47058823527
Net tangible assets: 48303422.051470585
Owner earnings: -22329170.889705878
Return on net tangible assets (%): -46.22689230156949
Buffett classification: The Gruesome
Stock price: 1.0073529411764706
Shares outstanding: 810857272
Book value: 48303422.05147058
P/B ratio: 16.910177853510106
Market cap (USD): 816819457.8235294
Debt to equity: 0.00616656468258484
Current ratio: 28.015520565855454
Quick ratio: 28.015520565855454
Interest coverage ratio: -15091.299273609899
Free cash flow (dilution-adjusted): -26395003.33823529
Buyback yield (%): 0
Retained earnings: -71841165.74264705
Receivables turnover: 0
Capitalized R&D asset: 1141.6377952755906
ROCI (R&D-adjusted, %): -51.410854479098
Rule of 40 score: 0
Financial ratios for DSV.TO — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -207276.28787878787
Operating income: -11202843.106060605
Net income: -8995721.007575758
Capital expenditures: 19277884.568181816
Operating cash flow: -871191.5606060607
Depreciation & amortization: 207721.71969696967
Net tangible assets: 74131060.60606061
Owner earnings: -28065883.856060605
Return on net tangible assets (%): -37.859816960134076
Buffett classification: The Gruesome
Stock price: 0.5757575757575757
Shares outstanding: 810857272
Book value: 74131060.60606061
P/B ratio: 6.297727476112127
Market cap (USD): 466857217.2121211
Debt to equity: 0.0023020559410544387
Current ratio: 5.083251820454299
Quick ratio: 5.083251820454299
Interest coverage ratio: -1030.8689266040847
Free cash flow (dilution-adjusted): -23440461.833333332
Buyback yield (%): 0
Retained earnings: -84977272.72727272
Receivables turnover: 0
Capitalized R&D asset: 562.2992125984252
ROCI (R&D-adjusted, %): -14.60755270740273
Rule of 40 score: 0
Financial ratios for DSV.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 43328.3037037037
Buffett classification: The Gruesome
Stock price: 0.5111111111111111
Shares outstanding: 810857272
Market cap (USD): 414438161.24444443
Buyback yield (%): 0
Capitalized R&D asset: 257285.9259259259
Rule of 40 score: 0
Financial ratios for DSV.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 49849.244755244756
Buffett classification: The Gruesome
Stock price: 0.4965034965034965
Shares outstanding: 810857272
Market cap (USD): 402593470.7132867
Buyback yield (%): 0
Capitalized R&D asset: 172381.57037037035
Rule of 40 score: 0
Financial ratios for DSV.TO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -9860139.86013986
Net income: -10606293.706293706
Capital expenditures: 5066433.566433567
Operating cash flow: -10588111.88811189
Depreciation & amortization: 193706.2937062937
Net tangible assets: 54425174.82517483
Owner earnings: -15479020.97902098
Return on net tangible assets (%): -28.440921005293724
Buffett classification: The Gruesome
Stock price: 0.4965034965034965
Shares outstanding: 810857272
Book value: 54425174.82517483
P/B ratio: 7.397192053245618
Market cap (USD): 402593470.7132867
Debt to equity: 0.013080125404738654
Current ratio: 3.8330548128342246
Quick ratio: 3.8330548128342246
Interest coverage ratio: -168.17934645505966
Free cash flow (dilution-adjusted): -17920279.72027972
Buyback yield (%): 0
Retained earnings: -89046853.14685315
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.754385081279825
Rule of 40 score: 0
Financial ratios for DSV.TO — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -4661538.461538462
Net income: -4511888.1118881125
Capital expenditures: 2634265.7342657344
Operating cash flow: -4247552.447552448
Depreciation & amortization: 40559.44055944056
Net tangible assets: 51453347.8881119
Owner earnings: -7105594.405594407
Return on net tangible assets (%): -13.809780504557075
Buffett classification: The Gruesome
Stock price: 1.4825174825174827
Shares outstanding: 810857272
Book value: 51453347.88811189
P/B ratio: 23.36310718168403
Market cap (USD): 1202110081.5664337
Debt to equity: 0.012753804038386682
Current ratio: 2.4055385307133768
Quick ratio: 2.4055385307133768
Interest coverage ratio: -52.90476190476191
Free cash flow (dilution-adjusted): -7697902.097902099
Buyback yield (%): 0
Retained earnings: -87227150.64335665
Receivables turnover: 0
Capitalized R&D asset: 84904.35555555555
ROCI (R&D-adjusted, %): -9.023277850426128
Rule of 40 score: 0
Financial ratios for DSV.TO — quarterly report dated 2025-06-30
Total revenue: 103656934.30656934
Gross profit: 50212408.759124085
Operating income: 31482481.751824815
Net income: 4039416.05839416
Capital expenditures: 29026277.372262772
Operating cash flow: 48964233.576642334
Depreciation & amortization: 11948175.18248175
Net tangible assets: 366414598.54014593
Owner earnings: -13038686.131386861
Return on net tangible assets (%): -3.5584515964525054
Capex to operating income (%): 92.19818691892144
Buffett classification: The Gruesome
Stock price: 2.1751824817518246
P/E ratio: 109.15949903144198
Shares outstanding: 810857272
Book value: 366414598.5401461
P/B ratio: 4.81357058447612
Market cap (USD): 1763762533.2554743
Debt to equity: 0
Current ratio: 2.3516033101368454
Quick ratio: 1.6755084578424277
Effective tax rate (%): 77.42146062831499
Interest coverage ratio: 3.0146781295869154
COGS to revenue (%): 51.55904513766636
SG&A to revenue (%): 5.781987184001126
Free cash flow (dilution-adjusted): 18512408.75912409
Buyback yield (%): 0
Retained earnings: -93616788.32116787
Inventory turnover: 0.6480073634183254
Receivables turnover: 5.214437835059117
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0997629056171747
FCF margin (%): 17.859305682698405
Rule of 40 score: 17.859305682698405
Financial ratios for DSV.TO — quarterly report dated 2025-09-30
Total revenue: 170475539.56834534
Gross profit: 65258273.381294966
Operating income: 55164028.77697842
Net income: 30531654.676258996
Capital expenditures: 47967625.89928058
Operating cash flow: 110423021.58273382
Depreciation & amortization: 25743165.4676259
Net tangible assets: 405351798.5611511
Owner earnings: 8307194.244604319
Return on net tangible assets (%): 2.049378903483785
Capex to operating income (%): 86.95453715537703
Buffett classification: The Gruesome
Stock price: 3.7122302158273386
P/E ratio: 100.13874640629996
Shares outstanding: 810857272
Book value: 405351798.56115127
P/B ratio: 7.425867793177254
Market cap (USD): 3010088865.841727
Debt to equity: 0
Current ratio: 2.0420297331084063
Quick ratio: 1.8011720365645663
Effective tax rate (%): 40.322580645161295
Interest coverage ratio: 6.025776031434185
COGS to revenue (%): 61.719861074185204
SG&A to revenue (%): 2.709728605129114
Free cash flow (dilution-adjusted): 61449640.28776979
Buyback yield (%): 0
Retained earnings: -61738129.49640288
Inventory turnover: 2.821872346993903
Receivables turnover: 5.2265428558824825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.106661276605379
FCF margin (%): 36.04601601107355
Revenue growth (%): 64.46129794284425
Rule of 40 score: 100.5073139539178
Financial ratios for DSV.TO — quarterly report dated 2025-12-31
Total revenue: 200176642.3357664
Gross profit: 104516788.32116787
Operating income: 57065693.43065693
Net income: 47656204.37956204
Capital expenditures: 69579562.04379562
Operating cash flow: 119146715.32846715
Depreciation & amortization: 36325547.44525547
Net tangible assets: 458018978.1021897
Owner earnings: 14402189.781021893
Return on net tangible assets (%): 3.1444526252378537
Capex to operating income (%): 121.92888206702482
Buffett classification: The Gruesome
Stock price: 6.116788321167883
P/E ratio: 63.820595673738765
Shares outstanding: 810857272
Book value: 458018978.1021898
P/B ratio: 10.828901265303129
Market cap (USD): 4959842291.50365
Debt to equity: 0.010508600988707316
Current ratio: 1.8508419673190906
Quick ratio: 1.6358583569604155
Effective tax rate (%): -8.185719730235794
Interest coverage ratio: 5.502533783783784
COGS to revenue (%): 47.787720334594994
SG&A to revenue (%): 14.20205511920129
Free cash flow (dilution-adjusted): 49230656.93430657
Buyback yield (%): 0
Retained earnings: -14983211.678832116
Inventory turnover: 2.141720187609289
Receivables turnover: 5.061870131787811
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.173303688410689
FCF margin (%): 24.59360710613254
Revenue growth (%): 17.422501106391042
Rule of 40 score: 42.016108212523584
Financial ratios for DSV.TO — annual report dated 2025-12-31
Total revenue: 476797810.21897805
Gross profit: 220940145.98540145
Operating income: 139651824.81751823
Net income: 77963503.64963503
Capital expenditures: 150023357.66423357
Operating cash flow: 275710218.97810215
Depreciation & amortization: 74435036.49635036
Net tangible assets: 458018978.1021897
Owner earnings: 2375182.4817518294
Return on net tangible assets (%): 0.5185773069040595
Capex to operating income (%): 107.42670771417968
Buffett classification: The Gruesome
Stock price: 6.116788321167883
P/E ratio: 63.61748843142028
Shares outstanding: 810857272
Book value: 458018978.1021898
P/B ratio: 10.828901265303129
Market cap (USD): 4959842291.50365
Debt to equity: 0.010508600988707316
Current ratio: 1.8508419673190906
Quick ratio: 1.6358583569604155
Effective tax rate (%): 28.56521826365527
Interest coverage ratio: 4.950142302716688
COGS to revenue (%): 53.66166931766514
SG&A to revenue (%): 8.67802692230559
Free cash flow (dilution-adjusted): 122052554.74452554
Buyback yield (%): 0
Retained earnings: -14983211.678832116
Inventory turnover: 5.728375087839716
Receivables turnover: 12.0567942707372
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.660168605497546
FCF margin (%): 25.59838827457506
Rule of 40 score: 25.59838827457506
Financial ratios for EIFFL.NS — annual report dated 2022-03-31
Total revenue: 14808123.433997098
Gross profit: 3859949.887907161
Operating income: 647500.9890544639
Net income: 183304.76064881973
Capital expenditures: 7912.435711459844
Operating cash flow: -416721.61413688515
Depreciation & amortization: 361334.5641566662
Net tangible assets: 8342344.718449163
Owner earnings: 536726.8890940262
Return on net tangible assets (%): 6.433765412582991
Capex to operating income (%): 1.2219959266802443
Buffett classification: The Great
Stock price: 1.5416062244494264
P/E ratio: 208.56978417266188
Shares outstanding: 24800000
Book value: 8346300.936304893
P/B ratio: 4.5806920524569446
Market cap (USD): 38231834.36634578
Debt to equity: 0.5872965713382841
Current ratio: 2.2245633490435264
Quick ratio: 0.4976434710285555
Effective tax rate (%): 35.944700460829495
Interest coverage ratio: 1.7473309608540923
COGS to revenue (%): 73.93356487665865
SG&A to revenue (%): 9.689197613322648
Free cash flow (dilution-adjusted): -424634.049848345
Buyback yield (%): 0
Retained earnings: 899380.1925359357
Inventory turnover: 1.3327982019585807
Receivables turnover: 7.310546875
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.17998741346759
FCF margin (%): -2.8675750289429156
Rule of 40 score: -2.8675750289429156
Financial ratios for EIFFL.NS — annual report dated 2023-03-31
Total revenue: 16913520.097442146
Gross profit: 4611449.451887942
Operating income: 605359.317904994
Net income: 147381.24238733255
Capital expenditures: 272838.0024360536
Operating cash flow: 831912.3020706456
Depreciation & amortization: 342265.52984165656
Net tangible assets: 7852618.757612668
Owner earnings: 216808.76979293552
Return on net tangible assets (%): 2.760974096478983
Capex to operating income (%): 45.07042253521126
Buffett classification: The Good
Stock price: 1.7868453105968332
P/E ratio: 300.6743801652892
Shares outstanding: 24800000
Book value: 7855054.811205847
P/B ratio: 5.641432780276012
Market cap (USD): 44313763.702801466
Debt to equity: 0.5973019072724453
Current ratio: 2.06465313827277
Quick ratio: 0.5903728173666825
Effective tax rate (%): 29.239766081871345
Interest coverage ratio: 1.470414201183432
COGS to revenue (%): 72.73512890681262
SG&A to revenue (%): 11.385568198185222
Free cash flow (dilution-adjusted): 559074.299634592
Buyback yield (%): 0
Retained earnings: 979293.5444579781
Inventory turnover: 1.61651728553137
Receivables turnover: 6.185300668151449
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.2390158172231995
FCF margin (%): 3.305487541408613
Revenue growth (%): 14.217849228696943
Rule of 40 score: 17.523336770105555
Financial ratios for EIFFL.NS — annual report dated 2024-03-31
Total revenue: 12863652.716153016
Gross profit: 3918935.124115601
Operating income: 783067.5140904185
Net income: 262621.41743614344
Capital expenditures: 461686.0534836311
Operating cash flow: 1153615.5414318263
Depreciation & amortization: 336970.8598153256
Net tangible assets: 7996162.60942559
Owner earnings: 137906.22376783786
Return on net tangible assets (%): 1.7246550689862028
Capex to operating income (%): 58.95865237366004
Buffett classification: The Good
Stock price: 1.5822936660268714
P/E ratio: 149.4199646797956
Shares outstanding: 24800000
Book value: 7998560.978534597
P/B ratio: 4.9059928433096305
Market cap (USD): 39240882.91746641
Debt to equity: 0.5893553223388306
Current ratio: 2.1112224448897794
Quick ratio: 0.5100200400801603
Effective tax rate (%): 28.196721311475407
Interest coverage ratio: 1.8189415041782728
COGS to revenue (%): 69.5348186818309
SG&A to revenue (%): 10.123986203039061
Free cash flow (dilution-adjusted): 690730.3033936922
Buyback yield (%): 0
Retained earnings: 1229164.1683655113
Inventory turnover: 1.1669274092615771
Receivables turnover: 6.258459743290548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.125933300149327
FCF margin (%): 5.369628041390882
Revenue growth (%): -23.944556532034966
Rule of 40 score: -18.574928490644083
Financial ratios for EIFFL.NS — quarterly report dated 2025-03-31
Total revenue: 4089314.9403787698
Gross profit: 1499883.0956277763
Operating income: 498012.6256722001
Net income: 301613.28033668455
Capital expenditures: 0
Depreciation & amortization: 79494.97311199439
Net tangible assets: 8465045.592705166
Owner earnings: 381108.25344867894
Return on net tangible assets (%): 4.502140588316531
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.060683860427121
P/E ratio: 42.35967302363578
Shares outstanding: 24800000
Book value: 8466214.636427402
P/B ratio: 6.036341143384716
Market cap (USD): 51104959.7385926
Debt to equity: 0.5795360397680198
Current ratio: 2.0764667106130523
Quick ratio: 0.47703801362337966
Effective tax rate (%): 28.133704735376046
Interest coverage ratio: 5.011764705882353
COGS to revenue (%): 63.321898227558606
Buyback yield (%): 0
Retained earnings: 1852934.2997428102
Inventory turnover: 0.30430004121445253
Receivables turnover: 2.0858676207513414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.107301282819806
Rule of 40 score: 0
Financial ratios for EIFFL.NS — annual report dated 2025-03-31
Total revenue: 16803834.463408932
Gross profit: 5454758.007949497
Operating income: 1243862.520458265
Net income: 654664.4844517184
Capital expenditures: 251344.40028057047
Operating cash flow: 1012391.8634556931
Depreciation & amortization: 322656.0673369184
Net tangible assets: 8465045.592705166
Owner earnings: 725976.1515080662
Return on net tangible assets (%): 8.576163513326888
Capex to operating income (%): 20.206766917293233
Buffett classification: The Great
Stock price: 2.060683860427121
P/E ratio: 78.06282600070021
Shares outstanding: 24800000
Book value: 8466214.636427402
P/B ratio: 6.036341143384716
Market cap (USD): 51104959.7385926
Debt to equity: 0.5795360397680198
Current ratio: 2.0764667106130523
Quick ratio: 0.47703801362337966
Effective tax rate (%): 22.437673130193907
Interest coverage ratio: 2.8834688346883466
COGS to revenue (%): 67.53861138166131
SG&A to revenue (%): 7.722276332266592
Free cash flow (dilution-adjusted): 761047.4631751227
Buyback yield (%): 0
Retained earnings: 1852934.2997428102
Inventory turnover: 1.3336996840225306
Receivables turnover: 8.571258199165177
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.756264236902052
FCF margin (%): 4.529010713788785
Revenue growth (%): 30.630349203288038
Rule of 40 score: 35.15935991707682
Financial ratios for ENSI.L — annual report dated 2022-05-31
Total revenue: 19358227.848101266
Gross profit: 6388607.594936709
Operating income: 892405.0632911392
Net income: 188607.59493670886
Capital expenditures: 349367.0886075949
Operating cash flow: 1760759.493670886
Depreciation & amortization: 418987.3417721519
Net tangible assets: 4527848.101265823
Owner earnings: 258227.8481012659
Return on net tangible assets (%): 5.7031031590718495
Capex to operating income (%): 39.148936170212764
Buffett classification: The Good
Stock price: 0.0064556962025316455
P/E ratio: 4.438196377852349
Shares outstanding: 129664953
Book value: 15383544.303797467
P/B ratio: 0.054413828708960756
Market cap (USD): 837077.5446835443
Debt to equity: 0.42450423763679757
Current ratio: 3.319609637084477
Quick ratio: 3.254040866117719
Interest coverage ratio: 1.247787610619469
COGS to revenue (%): 66.99797292879094
R&D to revenue (%): 0.09154515137644674
SG&A to revenue (%): 28.300529654090102
Free cash flow (dilution-adjusted): -1577215.1898734178
Buyback yield (%): 0
Retained earnings: 6478481.012658227
Inventory turnover: 47.65581395348836
Receivables turnover: 9.924075275794939
Capitalized R&D asset: 17721.518987341773
ROCI (R&D-adjusted, %): 4.308923472875699
FCF margin (%): -8.14751847250376
Rule of 40 score: -8.14751847250376
Financial ratios for ENSI.L — annual report dated 2023-05-31
Total revenue: 25279012.34567901
Gross profit: 10086419.75308642
Operating income: 1019753.086419753
Net income: 2212345.6790123456
Capital expenditures: 487654.32098765427
Operating cash flow: 2224691.358024691
Depreciation & amortization: 901234.5679012345
Net tangible assets: 4358024.691358024
Owner earnings: 2625925.925925926
Return on net tangible assets (%): 60.25495750708215
Capex to operating income (%): 47.82082324455206
Buffett classification: The Good
Stock price: 0.008518518518518517
P/E ratio: 0.4992679551897321
Shares outstanding: 129664953
Book value: 19707407.407407407
P/B ratio: 0.056047621105055435
Market cap (USD): 1104553.3033333332
Debt to equity: 0.40355822840318234
Current ratio: 2.1616756101782935
Quick ratio: 2.1090531417690848
Effective tax rate (%): -3712.7659574468084
Interest coverage ratio: 1.0522292993630573
COGS to revenue (%): 60.09962883375659
SG&A to revenue (%): 35.90545028325845
Free cash flow (dilution-adjusted): -3628395.0617283946
Buyback yield (%): 0
Retained earnings: 8793827.160493826
Inventory turnover: 40.48026315789474
Receivables turnover: 5.25969689185718
Capitalized R&D asset: 11873.417721518988
ROCI (R&D-adjusted, %): 3.78098367095982
Rosenberg metric: 208.6622574955908
FCF margin (%): -14.353389333854267
Revenue growth (%): 30.585364239105594
Rule of 40 score: 16.231974905251327
Financial ratios for ENSI.L — annual report dated 2024-05-31
Total revenue: 31982278.481012657
Gross profit: 11391139.240506329
Operating income: 1103797.4683544303
Net income: -230379.74683544302
Capital expenditures: 1173417.7215189873
Operating cash flow: 5405063.29113924
Depreciation & amortization: 1034177.2151898734
Net tangible assets: 4858227.848101266
Owner earnings: -369620.25316455704
Return on net tangible assets (%): -7.608129233976031
Capex to operating income (%): 106.30733944954129
Buffett classification: The Gruesome
Stock price: 0.00569620253164557
Shares outstanding: 129664953
Book value: 28358227.84810127
P/B ratio: 0.026045274673034857
Market cap (USD): 738597.8335443038
Debt to equity: 0.273088425657278
Current ratio: 1.732123090546823
Quick ratio: 1.6487713083905247
Interest coverage ratio: 0.9427027027027026
COGS to revenue (%): 64.38296524974274
SG&A to revenue (%): 32.31615609910552
Free cash flow (dilution-adjusted): -4215189.873417721
Buyback yield (%): 0
Retained earnings: 9379746.835443037
Inventory turnover: 21.60292164674635
Receivables turnover: 14.495697074010327
Capitalized R&D asset: 5848.1012658227855
ROCI (R&D-adjusted, %): 3.077765263267214
FCF margin (%): -13.179767276181428
Revenue growth (%): 26.5171203829862
Rule of 40 score: 13.337353106804771